Program

In-person AND virtual! – We are pioneering a new conference format that will connect in-person and virtual audiences to create a unique experience. Matching the innovation that comes through our members’ work, ISPOR is pushing the boundaries of innovation to design an event that works in today’s quickly changing environment. 

In-person registration included the full virtual experience, and virtual-only attendees will be able to tune into live in-person sessions and/or watch captured in-person sessions on-demand in addition to having a variety of virtual-only sessions to attend.

Economic Burden of Patients with Gastroesophageal Reflux Disease in Chinese

Speaker(s)

Yu X1, Hou X1, Sheng Y2, Xie L2
1Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 42, China, 2Medical Affairs, Takeda (China) International Trading Company, Beijing, China

Presentation Documents

Objectives: Gastroesophageal reflux disease (GERD) has a prevalence of 4.2% in China, causing troublesome symptoms and economic strain with direct and indirect costs that adversely impact patients’ quality of life. This real-world study aimed to assess the economic burden of GERD patients in China by collecting data on cost and utilization of medical resources.

Methods: This study was conducted using electronic medical records of patients diagnosed with GERD in 2 hospitals from January 2015 to December 2017. Medical resource utilization and economic burden of GERD patients was analyzed. Patients were categorized into non-erosive reflux disease (NERD), reflux esophagitis (RE) and Barrett’s esophagus (BE) on the basis of endoscopic assessment report. Average number of annual visits, average medication cost and average investigation cost of these three groups were quantitatively described.

Results: 12,658 GERD patients were included. Average number of annual visits for GERD patients was 1.16, where average medication cost per visit was CNY 206.91, and average cost for investigation per visit was CNY 462.71. Among 22.7% patients underwent gastroscopy, NERD patients accounted for highest proportion (78.2%), followed by RE patients (21.3%) and BE patients (0.5%). For NERD, RE, and BE patients, average number of annual visits were 1.23, 1.38 and 1.36 respectively, average costs for medication were CNY 95.52, CNY 149.85 and CNY 192.76 respectively, and average investigation costs were CNY 790.57, CNY 885.03 and CNY 1117.94 respectively.

Conclusion: Our results demonstrate that number of visits and medical expense have a tendency to increase with aggravation of disease severity, which is worthy of attracting clinical attention.

Code

EE195

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Gastrointestinal Disorders